All News

Take this brief quiz to see what you’ve learned about the challenges and opportunities of obesity management.

Following are answers to the questions primary care physicians most often ask.

As with any other chronic disease, a detailed medical history is important. Individualized interventions recommended.

Cardiovascular risk/benefit profiles of pioglitazone and the SGLT2 inhibitor class are summarized, based on reports at ADA 2017.

Often efforts are made in treating the consequences more than the primary cause.

Here are answers to the questions primary care physicians most often ask about patient evaluation.

A rare finding is a timely lesson for all clinicians who are touched in one way or another by the injectable drug crisis in the US.

The answers in this Patient Care Special Report offer easy steps PCPs can take for more efficient and effective treatment.

A 69-year-old in an active surveillance program asks what the revised USPSTF position on PSA testing means for guys like him.

Try these 10 questions and see what you've learned during this month's special report on the nuts-and-bolts of T2DM for PCPs.

What characteristics of new drugs might help predict safety issues years later? Find answers and tips on what classes to watch.

Patient describes 2 short "spells," one of blurry vision and another of tingling in an extremity. Tinnitus begins in your office.

Note to new grads: "Transparency and accountability will be major themes as we move forward -- basically, 'No outcome, no income.'"

A new evidence-based clinical practice guideline addresses adverse events, surgical risks, and patient education

Special Report recap: the current and future state of RA patient care and what PCPs will need to know to do their part.

Some eager medical cannabis experts ask why cannabidiol is not mandatory for athletes to address TBI. Others are more cautious.